Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.

Cells isolated from many types of human cancers express heparin-binding growth factors (HBGFs) that drive tumor growth, metastasis, and angiogenesis. The heparan sulfate proteoglycan glypican-1 (GPC1) is a coreceptor for HBGFs. Here we show that both cancer cell-derived and host-derived GPC1 are crucial for efficient growth, metastasis, and angiogenesis of human and mouse cancer cells. Thus downregulation of GPC1 in the human pancreatic cancer cell line PANC-1, using antisense approaches, resulted in prolonged doubling times and decreased anchorage-independent growth in vitro as well as attenuated tumor growth, angiogenesis, and metastasis when these cells were transplanted into athymic mice. Moreover, athymic mice that lacked GPC1 exhibited decreased tumor angiogenesis and metastasis following intrapancreatic implantation with either PANC-1 or T3M4 human pancreatic cancer cells and fewer pulmonary metastases following intravenous injection of murine B16-F10 melanoma cells. In addition, hepatic endothelial cells isolated from these mice exhibited an attenuated mitogenic response to VEGF-A. These data indicate that cancer cell- and host-derived GPC1 are crucial for full mitogenic, angiogenic, and metastatic potential of cancer cells. Thus targeting GPC1 might provide new avenues for cancer therapy and for the prevention of cancer metastasis.

[1]  L. Ellis,et al.  Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. , 2001, Cancer biotherapy & radiopharmaceuticals.

[2]  A. Rapraeger.  In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding? , 1995, Chemistry & biology.

[3]  A. Friedl,et al.  Shedding of Syndecan-1 by Stromal Fibroblasts Stimulates Human Breast Cancer Cell Proliferation via FGF2 Activation* , 2007, Journal of Biological Chemistry.

[4]  M. Korc,et al.  Role of growth factors in pancreatic cancer. , 1998, Surgical oncology clinics of North America.

[5]  H. Friess,et al.  Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  S. Selleck,et al.  Order out of chaos: assembly of ligand binding sites in heparan sulfate. , 2002, Annual review of biochemistry.

[7]  M. Sheikh.  Radiosensitivity with Par-4 Expression in Prostate Cancer , 2002, Cancer biology & therapy.

[8]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[9]  M. Hendrix,et al.  Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells , 2000, Breast Cancer Research.

[10]  M. Korc,et al.  Growth factor–induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells , 2005, The Journal of cell biology.

[11]  M. Löhr,et al.  Expression and Function of Receptors for Extracellular Matrix Proteins in Human Ductal Adenocarcinomas of the Pancreas , 1996, Pancreas.

[12]  H. Friess,et al.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. , 1998, The Journal of clinical investigation.

[13]  J. Filmus,et al.  Glypicans in growth control and cancer. , 2001, Glycobiology.

[14]  C. Tait,et al.  Angiopoietins in tumours: the angiogenic switch , 2004, The Journal of pathology.

[15]  Ji-Hye Kim,et al.  Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway , 2000, Oncogene.

[16]  J. Esko,et al.  Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis , 2007, The Journal of cell biology.

[17]  M. Korc,et al.  Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines , 2004, Clinical Cancer Research.

[18]  R. Hruban,et al.  Molecular pathogenesis of pancreatic cancer. , 2006, Best practice & research. Clinical gastroenterology.

[19]  G. Neufeld,et al.  Glypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165 * , 1999, The Journal of Biological Chemistry.

[20]  K. Suzuma,et al.  Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[21]  J. Kreuger,et al.  Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. , 2006, Developmental cell.

[22]  G. David.  Integral membrane heparan sulfate proteoglycans , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[24]  M. J. Jarzynka,et al.  Angiopoietin-2 Stimulates Breast Cancer Metastasis through the α5β1 Integrin-Mediated Pathway , 2007 .

[25]  Richard A. Lang,et al.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Lander,et al.  Mechanisms Underlying Preferential Assembly of Heparan Sulfate on Glypican-1* , 2001, The Journal of Biological Chemistry.

[27]  N. Yang,et al.  Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. , 2003, Cancer research.

[28]  G. David,et al.  Developmental roles of the glypicans. , 2001, Seminars in cell & developmental biology.

[29]  N. Sergeant,et al.  Proteoglycans: Pericellular and Cell Surface Multireceptors that Integrate External Stimuli in the Mammary Gland , 2001, Journal of Mammary Gland Biology and Neoplasia.

[30]  H. Friess,et al.  Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  M. Korc,et al.  Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis. , 2002, Molecular cancer therapeutics.

[32]  M. Korc,et al.  Pathways for aberrant angiogenesis in pancreatic cancer , 2003, Molecular Cancer.

[33]  G. Yancopoulos,et al.  The angiopoietins: Yin and Yang in angiogenesis. , 1999, Current topics in microbiology and immunology.

[34]  A. Lander,et al.  Expression of the heparan sulfate proteoglycan glypican‐1 in the developing rodent , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  J. Partanen,et al.  Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. , 1999, Current topics in microbiology and immunology.

[36]  C. Garlanda,et al.  A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[37]  A. Friedl,et al.  Heparan Sulfate Proteoglycans as Regulators of Fibroblast Growth Factor-2 Signaling in Brain Endothelial Cells , 2003, The Journal of Biological Chemistry.

[38]  M. Korc,et al.  Coexpression of FAS and FAS-Ligand in Chronic Pancreatitis: Correlation with Apoptosis , 2000, Pancreas.

[39]  M. Korc,et al.  Pancreatic cancer cell‐derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo , 2001, International journal of cancer.

[40]  S. McKenna,et al.  The medical management of pancreatic cancer: a review. , 2003, The oncologist.

[41]  H. Friess,et al.  Induction and expression of amphiregulin in human pancreatic cancer. , 1994, Cancer research.

[42]  K. Aldape,et al.  Expression of the Receptor Tyrosine Kinase Tie2 in Neoplastic Glial Cells Is Associated with Integrin β1-Dependent Adhesion to the Extracellular Matrix , 2006, Molecular Cancer Research.

[43]  M. Korc,et al.  Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. , 1998, The Journal of clinical investigation.

[44]  J. Folkman,et al.  Angiogenesis and apoptosis. , 2003, Seminars in cancer biology.

[45]  H. Friess,et al.  Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. , 1999, Pancreas.

[46]  Z. Fuks,et al.  Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis , 1990, Cancer and Metastasis Reviews.

[47]  G. Koh,et al.  Angiopoietin‐1 is an apoptosis survival factor for endothelial cells , 1999, FEBS letters.

[48]  N. Perrimon,et al.  Cellular functions of proteoglycans--an overview. , 2001, Seminars in cell & developmental biology.

[49]  A. Lander,et al.  The glypican family of heparan sulfate proteoglycans: major cell-surface proteoglycans of the developing nervous system. , 1996, Perspectives on developmental neurobiology.

[50]  Qing Nie,et al.  Do morphogen gradients arise by diffusion? , 2002, Developmental cell.

[51]  M. Kan,et al.  The heparan sulfate-fibroblast growth factor family: diversity of structure and function. , 1998, Progress in nucleic acid research and molecular biology.

[52]  M. Korc,et al.  Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells , 2004, Clinical Cancer Research.

[53]  H. Friess,et al.  Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. , 1994, Biochemical and biophysical research communications.

[54]  L. Suva,et al.  Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[55]  F. Zhan,et al.  Heparanase Enhances Syndecan-1 Shedding , 2007, Journal of Biological Chemistry.

[56]  P. Marynen,et al.  Glypican-6, a New Member of the Glypican Family of Cell Surface Heparan Sulfate Proteoglycans* , 1999, The Journal of Biological Chemistry.